rakuten-med.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $2.96B
Rakuten Medical is a biotechnology company that strives to develop cancer treatments. Their approach involves the use of cell-targeting therapies that are administered through the company’s proprietary Alluminox platform. Rakuten Medical was founded in 2010 and is headquartered in San Diego, CA. The platform is based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and the team at the U.S.-based National Cancer Institute. The global company focuses on the development and commercialization of its precision-based therapies designed to treat a variety of cancers.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/18/2023 | Series E-1 | $57.77MM | $xx.xx | $825.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
38,596,118
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series E | $39.2MM | $xx.xx | $825.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
20,951,055
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series E-2 | $3.92MM | $xx.xx | $825.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,095,105
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series E-3 | $3.92MM | $xx.xx | $825.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,095,105
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/28/2021 | Series D | $166MM | $xx.xx | $1.71B | General Catalyst, Rakuten, Sbi Group | |
Price per Share
$xx.xx
Shares Outstanding
36,051,689
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst, Rakuten, Sbi Group
|
||||||
12/31/2020 | Series C-2 | $15MM | $xx.xx | $1.5B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,344,482
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/31/2019 | Series C-1 | $100.79MM | $xx.xx | $1.11B | Rakuten | |
Price per Share
$xx.xx
Shares Outstanding
26,967,678
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Rakuten
|
||||||
12/21/2018 | Series C | $284.69MM | $xx.xx | $809.7MM | Rakuten, Sbi Group | |
Price per Share
$xx.xx
Shares Outstanding
91,254,907
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Rakuten, Sbi Group
|
||||||
09/12/2017 | Series B-1 | $19MM | $xx.xx | $213.26MM | Hiroshi Mikitani | |
Price per Share
$xx.xx
Shares Outstanding
19,820,542
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Hiroshi Mikitani
|
||||||
10/05/2016 | Series B | $56.12MM | $xx.xx | $119.8MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
86,846,168
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/30/2015 | Series A | $14.32MM | $xx.xx | $68.25MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
31,127,769
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|